New strategic collaboration to accelerate treatments for unmet medical needs in oncology
The University of Texas MD Anderson Cancer Center and Taiho Pharmaceutical Co., Ltd., today announced a three-year strategic collaboration to accelerate the development of treatments for significant unmet medical needs in oncology, including patients with brain metastases and those with cancers refractory to available therapies.
.png)
No hay comentarios:
Publicar un comentario